COMMUNIQUÉS West-GlobeNewswire

Merus to Participate in Citi’s 13th Annual Biotech Conference

30/08/2018 - 13:00

UTRECHT, The Netherlands, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

CRISPR Therapeutics to Present at Upcoming Investor Conferences

30/08/2018 - 13:00

ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

Tonix Pharmaceuticals to Present at Upcoming September Investor Conferences

30/08/2018 - 13:00

NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company [...]

VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis

30/08/2018 - 13:00

These data, together with positive preclinical NASH data previously presented, support the potential of VBL’s lecinoxoid pipeline Recently granted US patent provides patent protection for lecinoxoids treatment of [...]

ChromaDex Announces Participation at The 20th Annual Global Investment Conference in New York City September 5, 2018

30/08/2018 - 12:30

IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]

Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm

30/08/2018 - 10:30

Nasdaq Stockholm’s Listing Committee has approved the admission of Infant Bacterial Therapeutics AB’s (“IBT” or the “Company”) shares of series B for trading on the main market of Nasdaq Stockholm. The approval is [...]

Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.

30/08/2018 - 10:01

Press release Malmö, August 30, 2018 Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease. Acarix AB (publ) ("Acarix"), [...]

LIDDS Delårsrapport april-juni 2018

30/08/2018 - 08:31

ANDRA KVARTALET (APRIL - JUNI 2018) Nettoomsättningen uppgick till 0,0 (0,4) MSEK Kostnaderna uppgick till 2,2 (1,6) MSEK Resultatet före och efter skatt uppgick till -2,2 (-1,2) MSEK Resultat per aktie uppgick till -0, [...]

Notification from Oasmia Pharmaceutical AB

30/08/2018 - 08:30

Oasmia Pharmaceutical AB hereby issues a notification that the Company’s loan from Nexttobe AB has according to earlier communication been overtaken by a consortium. Due date for the loan is September 30 th 2019. Notes [...]

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Herantis Pharma Oyj: Manager's Transactions - James Phillips

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - James Phillips Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Herantis Pharma Oyj: Manager's Transactions - Aki Prihti

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - Aki Prihti Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Herantis Pharma Oyj: Manager's Transactions - Frans Wuite

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - Frans Wuite Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Herantis Pharma Oyj: Manager's Transactions - Pekka Mattila

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - Pekka Mattila Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Herantis Pharma Oyj: Manager's Transactions - Timo Veromaa

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - Timo Veromaa Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto

30/08/2018 - 08:01

Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Patrick Bourdet, fondateur et ancien PDG d’AREVA Med (Orano Med) entre au capital du Radiopharma Logistics Group (RLG)

30/08/2018 - 08:00

Médicine Nucléaire/ Radiopharmacie/Logistique Loos, France, siège d'Isovital, 28 aout 2018 : Patrick Bourdet, fondateur et ancien PDG d’AREVA Med (Orano Med) entre au capital du Radiopharma Logistics Group (RLG). [...]

Shire plc: Rule 2.9 Announcement

30/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 August 2018 [...]

NeuroSearch A/S – H1 report 2018

30/08/2018 - 08:00

Announcement 30 August 2018 Below please find the H1 report 2018. The full report is available in the enclosed PDF file. NeuroSearch posted an operating loss of DKK 2.8 million in H1 2018 (H2 2017: a loss of DKK 2.3 [...]